Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

Small Intestinal Bacterial Overgrowth and Orocecal Transit Time in Patients of Inflammatory Bowel Disease

Published:2013-05-07 Issue:9 Volume:58 Page:2594-2598
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Rana S. V.,Sharma S.,Malik A.,Kaur J.,Prasad K. K.,Sinha S. K.,Singh K.

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-013-2694-x.pdf

Reference24 articles.

1. Kmiec Z. Cytokines in inflammatory bowel disease. Arch Immunol Ther Exp (Warsz). 1998;46:143–155.

2. Kathleen A, Jurenka JS. Inflammatory bowel disease part 1: ulcerative colitis pathophysiology and conventional and alternative treatment options. Altern Med Rev. 2003;8:247–283.

3. Ardizzone S, Bianchi Porro G. Biologic therapy for inflammatory bowel disease. Drugs. 2005;65:2253–2286.

4. Ardizzone S, Bollani S, Manzionna G, Bianchi Porro G. Inflammatory bowel disease approaching the 3rd millennium: pathogenesis and therapeutic implications? Eur J Gastroenterol Hepatol. 1999;11:27–32.

5. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology. 1998;115:182–205.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Update of gut gas metabolism in ulcerative colitis;Expert Review of Gastroenterology & Hepatology;2024-07-02

2. The Role of Methanogenic Archaea in Inflammatory Bowel Disease—A Review;Journal of Personalized Medicine;2024-02-10

3. Multi-effect formulation based on pH-Responsive psyllium Mucilage/Poly(vinyl alcohol) nanofibers for controlled delivery of mesalamine;Journal of Drug Delivery Science and Technology;2024-02

4. Methanogenic Archaea in the Pediatric Inflammatory Bowel Disease in Relation to Disease Type and Activity;International Journal of Molecular Sciences;2024-01-04

5. Colonic disorder management: challenges and prospects;Advanced Drug Delivery Systems for Colonic Disorders;2024